Exact Mass: 408.1362
Exact Mass Matches: 408.1362
Found 272 metabolites which its exact mass value is equals to given mass value 408.1362,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Marmesin galactoside
Nodakenin is a furanocoumarin. Nodakenin is a natural product found in Hansenia forbesii, Rhodiola rosea, and other organisms with data available. Marmesin galactoside is found in herbs and spices. Marmesin galactoside is a constituent of Murraya koenigii (curry leaf tree). Constituent of Murraya koenigii (curry leaf tree). Marmesin galactoside is found in herbs and spices. Nodakenin is a major coumarin glucoside in the root of Angelica decusiva. Nodakenin inhibits acetylcholinesterase (AChE) activity with an IC50 of 84.7 μM[1][2]. Nodakenin is a major coumarin glucoside in the root of Angelica decusiva. Nodakenin inhibits acetylcholinesterase (AChE) activity with an IC50 of 84.7 μM[1][2].
Amlodipine
Amlodipine is a long-acting calcium channel blocker used as an anti-hypertensive and in the treatment of angina. As other calcium channel blockers, amlodipine acts by relaxing the smooth muscle in the arterial wall, decreasing peripheral resistance and hence improving blood pressure; in angina it improves blood flow to the myocardium. It was developed under the direction of Dr. Simon Campbell; A long acting dihydropyridine calcium channel blocker. It is effective in the treatment of angina pectoris and hypertension; in angina it improves blood flow to the myocardium.; Amlodipine (as besylate, mesylate or maleate) is a long-acting calcium channel blocker used as an anti hypertensive and in the treatment of angina. Amlodipine is marketed as Norvasc in North America and as Istin in the United Kingdom as well as under various other names. As other calcium channel blockers, amlodipine acts by relaxing the smooth muscle in the arterial wall, decreasing peripheral resistance and hence improving blood pressure; Amlodipine (as besylate, mesylate or maleate) is a long-acting calcium channel blocker used as an anti-hypertensive and in the treatment of angina. Amlodipine is marketed as Norvasc in North America and as Istin in the United Kingdom as well as under various other names. As other calcium channel blockers, amlodipine acts by relaxing the smooth muscle in the arterial wall, decreasing peripheral resistance and hence improving blood pressure; in angina it improves blood flow to the myocardium. It was developed under the direction of Dr. Simon Campbell. [HMDB] Amlodipine is a long-acting calcium channel blocker used as an anti-hypertensive and in the treatment of angina. As other calcium channel blockers, amlodipine acts by relaxing the smooth muscle in the arterial wall, decreasing peripheral resistance and hence improving blood pressure; in angina it improves blood flow to the myocardium. It was developed under the direction of Dr. Simon Campbell; A long acting dihydropyridine calcium channel blocker. It is effective in the treatment of angina pectoris and hypertension; in angina it improves blood flow to the myocardium. Amlodipine (as besylate, mesylate or maleate) is a long-acting calcium channel blocker used as an anti hypertensive and in the treatment of angina. Amlodipine is marketed as Norvasc in North America and as Istin in the United Kingdom as well as under various other names. As other calcium channel blockers, amlodipine acts by relaxing the smooth muscle in the arterial wall, decreasing peripheral resistance and hence improving blood pressure; Amlodipine (as besylate, mesylate or maleate) is a long-acting calcium channel blocker used as an anti-hypertensive and in the treatment of angina. Amlodipine is marketed as Norvasc in North America and as Istin in the United Kingdom as well as under various other names. As other calcium channel blockers, amlodipine acts by relaxing the smooth muscle in the arterial wall, decreasing peripheral resistance and hence improving blood pressure; in angina it improves blood flow to the myocardium. It was developed under the direction of Dr. Simon Campbell. C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Ginkgolide A
Ginkgolide A is found in fats and oils. Ginkgolide A is a bitter principle from Ginkgo biloba (ginkgo). Ginkgolide A (BN-52020) is an extract from in Ginkgo biloba and a g-aminobutyric acid (GABA) antagonist. Ginkgolide A (BN-52020) is an extract from in Ginkgo biloba and a g-aminobutyric acid (GABA) antagonist. Ginkgolide A (BN-52020) is an extract from in Ginkgo biloba and a g-aminobutyric acid (GABA) antagonist.
11beta-Hydroxy-12alpha-bromoprogesterone
Trifloxystrobin
A carboxylic ester that is the methyl ester of (2E)-(methoxyimino)[2-({[(E)-{1-[3-(trifluoromethyl)phenyl]ethylidene}amino]oxy}methyl)phenyl]acetate. A foliar applied fungicide for cereals which is particularly active against Ascomycetes, Deuteromycetes and Oomycetes D010575 - Pesticides > D005659 - Fungicides, Industrial > D000073739 - Strobilurins D016573 - Agrochemicals CONFIDENCE standard compound; INTERNAL_ID 1112; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9856; ORIGINAL_PRECURSOR_SCAN_NO 9854 CONFIDENCE standard compound; INTERNAL_ID 1112; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9876; ORIGINAL_PRECURSOR_SCAN_NO 9874 CONFIDENCE standard compound; INTERNAL_ID 1112; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9867; ORIGINAL_PRECURSOR_SCAN_NO 9866 CONFIDENCE standard compound; INTERNAL_ID 1112; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9910; ORIGINAL_PRECURSOR_SCAN_NO 9909 CONFIDENCE standard compound; INTERNAL_ID 1112; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9929; ORIGINAL_PRECURSOR_SCAN_NO 9928 CONFIDENCE standard compound; INTERNAL_ID 1112; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9927; ORIGINAL_PRECURSOR_SCAN_NO 9925 CONFIDENCE standard compound; INTERNAL_ID 4012 CONFIDENCE standard compound; INTERNAL_ID 3714
dapagliflozin
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BK - Sodium-glucose co-transporter 2 (sglt2) inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent D007004 - Hypoglycemic Agents > D000077203 - Sodium-Glucose Transporter 2 Inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C98083 - SGLT2 Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Nelociguat
A member of the class of pyrazolopyridines that is 1H-pyrazolo[3,4-b]pyridine which is substituted by a 2-fluorobenzyl and 4,6-diamino-5-[(methoxycarbonyl)amino]pyrimidin-2-yl groups at positions 1 and 3, respectively. It is an active metabolite of riociguat and a soluble guanylate cyclase stimulator developed by Bayer for the treatment of erectile dysfunction and heart failure. C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent
Wybutoxine
Wybutoxine is found in animal foods. Wybutoxine is a constituent of phenylalanine tRNA of beef, chicken, calf and rat livers. Constituent of phenylalanine tRNA of beef, chicken, calf and rat livers. Wybutoxine is found in animal foods.
Torachrysone 8-glucoside
Torachrysone 8-glucoside is found in garden rhubarb. Torachrysone 8-glucoside is isolated from Rhei rhizoma. Isolated from Rhei rhizoma. Torachrysone 8-glucoside is found in green vegetables and garden rhubarb. Torachrysone-8-O-b-D-glucoside could be isolated from root of Polygonum multiflorum. Torachrysone-8-O-b-D-glucoside increases the proliferation of DPCs (dermal papilla cells)[1]. Torachrysone-8-O-b-D-glucoside could be isolated from root of Polygonum multiflorum. Torachrysone-8-O-b-D-glucoside increases the proliferation of DPCs (dermal papilla cells)[1].
(2R,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
2-(2-Aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylic acid O3-ethyl ester O5-methyl ester;benzenesulfonic acid
Pasakbumin-A
Eurycomanone is a natural product found in Eurycoma longifolia with data available. Eurycomanone could increases spermatogenesis by inhibiting the activity of phosphodiesterase and aromatase in steroidogenesis.
3-[2-[3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl]-2,3-dihydrofuro[3,2-g]chromen-7-one
Tinnevellin glucoside
Tinnevellin glucoside is a natural product found in Senna alexandrina with data available.
Eurycomanone
A quassinoid isolated from Eurycoma longifolia and has been shown to exhibit antineoplastic and antimalarial activties. Eurycomanone is a natural product found in Eurycoma longifolia with data available. Eurycomanone could increases spermatogenesis by inhibiting the activity of phosphodiesterase and aromatase in steroidogenesis.
ginkgolide A
Bitter principle from Ginkgo biloba (ginkgo). Ginkgolide A is found in ginkgo nuts and fats and oils. relative retention time with respect to 9-anthracene Carboxylic Acid is 0.715 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.712 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.714 Ginkgolide A is a highly active PAF antagonist cage molecule that is isolated from the leaves of the Ginkgo biloba tree. Shows potential in a wide variety of inflammatory and immunological disorders. ginkgolide-A is a natural product found in Ginkgo biloba and Machilus wangchiana with data available. See also: Ginkgo (part of). Ginkgolide A (BN-52020) is an extract from in Ginkgo biloba and a g-aminobutyric acid (GABA) antagonist. Ginkgolide A (BN-52020) is an extract from in Ginkgo biloba and a g-aminobutyric acid (GABA) antagonist. Ginkgolide A (BN-52020) is an extract from in Ginkgo biloba and a g-aminobutyric acid (GABA) antagonist.
Ginkgolide A
9H-1,7a-(Epoxymethano)-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3,2:3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione, 3-tert-butylhexahydro-4,7b-dihydroxy-8-methyl- is a diterpene lactone. Ginkgolide A is a natural product found in Ginkgo biloba with data available. Ginkgolide A is found in fats and oils. Ginkgolide A is a bitter principle from Ginkgo biloba (ginkgo). Ginkgolide A (BN-52020) is an extract from in Ginkgo biloba and a g-aminobutyric acid (GABA) antagonist. Ginkgolide A (BN-52020) is an extract from in Ginkgo biloba and a g-aminobutyric acid (GABA) antagonist. Ginkgolide A (BN-52020) is an extract from in Ginkgo biloba and a g-aminobutyric acid (GABA) antagonist.
Tinnevellin
Tinnevellin glucoside is a natural product found in Senna alexandrina with data available.
5,3,4-Trihydroxybibenzyl 2-O-beta-D-glucopyranoside
isoarnottinin 4-glucoside|isoarnottinin-4-O-beta-D-glucoside
10-Desoxy-adifolin|9-hydroxy-8-methyl-10-oxa-1,7b-diaza-8a,9,12a,13-tetrahydro-benzo[5,6]cyclohepta[1,2,3-jk]fluorene-2,12-dicarboxylic acid 12-methyl ester
7-(4-but-1-enyl-2,5-dioxo-2,5-dihydro-furan-3-ylmethyl)-4,5-dicarboxy-non-5-enoic acid
6-O-(4-Hydroxy-2-methylene-butyryl)-1-O-trans-cinnamoyl-??-D-glucopyranose|Spirarin
(3S,4R)-4,2??5?-trihydroxy-6,7,8,3?,4?-pentamethoxyisoflavan|abruquinone G
6-O-(trans-cinnamoyl)-1-O-(3-methylfuran-2-on-4-yl)-beta-D-glucopyranose|6-O-(trans-Cinnamoyl)-1-O-(4-hydroxy-3-methylfuran-2-one)-??-D-glucopyranose
alpha-Hydroxy-3,5-dimethoxy-4-[alpha-(hydroxymethyl)-beta,4-dihydroxy-3-methoxyphenethyloxy]acetophenone
8-Me ether, 6-O-beta-D-glucopyranoside-2-Acetyl-1,6,8-trihydroxy-3-methylnaphthalene
Torachrysone8-O-glucoside
Torachrysone 8-O-Glucoside is a natural product found in Rheum palmatum, Rheum undulatum, and other organisms with data available. Torachrysone-8-O-b-D-glucoside could be isolated from root of Polygonum multiflorum. Torachrysone-8-O-b-D-glucoside increases the proliferation of DPCs (dermal papilla cells)[1]. Torachrysone-8-O-b-D-glucoside could be isolated from root of Polygonum multiflorum. Torachrysone-8-O-b-D-glucoside increases the proliferation of DPCs (dermal papilla cells)[1].
Ammajin
Marmesinin is a member of the class of psoralens that is (-)-marmesin in which the hydroxy hydrogen is replaced by a beta-D-glucosyl residue. It has a role as a plant metabolite, a P450 inhibitor and an antioxidant. It is a beta-D-glucoside, a member of psoralens and a monosaccharide derivative. It is functionally related to a nodakenetin. Ammijin is a natural product found in Prangos tschimganica, Hansenia forbesii, and other organisms with data available. A member of the class of psoralens that is (-)-marmesin in which the hydroxy hydrogen is replaced by a beta-D-glucosyl residue.
amlodipine
C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 1544
Consist
D010575 - Pesticides > D005659 - Fungicides, Industrial > D000073739 - Strobilurins CONFIDENCE standard compound; INTERNAL_ID 8386 D016573 - Agrochemicals CONFIDENCE standard compound; EAWAG_UCHEM_ID 3181 CONFIDENCE standard compound; INTERNAL_ID 3714 INTERNAL_ID 3714; CONFIDENCE standard compound
Nodakenin
Nodakenin is a furanocoumarin. Nodakenin is a natural product found in Hansenia forbesii, Rhodiola rosea, and other organisms with data available. Marmesin galactoside is a member of the class of compounds known as psoralens. Psoralens are organic compounds containing a psoralen moiety, which consists of a furan fused to a chromenone to for 7H-furo[3,2-g]chromen-7-one. Marmesin galactoside is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Marmesin galactoside can be found in herbs and spices, which makes marmesin galactoside a potential biomarker for the consumption of this food product. Nodakenin is a major coumarin glucoside in the root of Angelica decusiva. Nodakenin inhibits acetylcholinesterase (AChE) activity with an IC50 of 84.7 μM[1][2]. Nodakenin is a major coumarin glucoside in the root of Angelica decusiva. Nodakenin inhibits acetylcholinesterase (AChE) activity with an IC50 of 84.7 μM[1][2].
8-[2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl]-8,9-dihydrofuro[2,3-h]chromen-2-one
(1R,3R,6R,8S,10R,13S,16S,17R)-8-tert-butyl-6,17-dihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0¹,¹¹.0³,⁷.0⁷,¹¹.0¹³,¹⁷]nonadecane-5,15,18-trione
(1S,3R,6R,7S,8S,10R,13S,16S,17R)-8-tert-butyl-6,17-dihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0¹,¹¹.0³,⁷.0⁷,¹¹.0¹³,¹⁷]nonadecane-5,15,18-trione
8-[2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl]-8,9-dihydrofuro[2,3-h]chromen-2-one
8-[2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl]-8,9-dihydrofuro[2,3-h]chromen-2-one_major
(1S,3R,6R,7S,8S,10R,13S,16S,17R)-8-tert-butyl-6,17-dihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0¹,¹¹.0³,⁷.0⁷,¹¹.0¹³,¹⁷]nonadecane-5,15,18-trione_major
(1S,3R,6R,7S,8S,10R,13S,16S,17R)-8-tert-butyl-6,17-dihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0¹,¹¹.0³,⁷.0⁷,¹¹.0¹³,¹⁷]nonadecane-5,15,18-trione_41.2\\%
(1S,3R,6R,7S,8S,10R,13S,16S,17R)-8-tert-butyl-6,17-dihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0¹,¹¹.0³,?.0?,¹¹.0¹³,¹?]nonadecane-5,15,18-trione
Ala Cys Asp Thr
Ala Cys Glu Ser
Ala Cys Ser Glu
Ala Cys Thr Asp
Ala Asp Cys Thr
Ala Asp Thr Cys
Ala Glu Cys Ser
Ala Glu Ser Cys
Ala Ser Cys Glu
Ala Ser Glu Cys
Ala Thr Cys Asp
Ala Thr Asp Cys
Cys Ala Asp Thr
Cys Ala Glu Ser
Cys Ala Ser Glu
Cys Ala Thr Asp
Cys Asp Ala Thr
Cys Asp Thr Ala
Cys Glu Ala Ser
Cys Glu Gly Thr
Cys Glu Ser Ala
Cys Glu Thr Gly
Cys Gly Glu Thr
Cys Gly Thr Glu
Cys Ser Ala Glu
Cys Ser Glu Ala
Cys Thr Ala Asp
Cys Thr Asp Ala
Cys Thr Glu Gly
Cys Thr Gly Glu
Asp Ala Cys Thr
Asp Ala Thr Cys
Asp Cys Ala Thr
Asp Cys Thr Ala
Asp Gly Met Ser
Asp Gly Ser Met
Asp Met Gly Ser
Asp Met Ser Gly
Asp Ser Gly Met
Asp Ser Met Gly
Asp Thr Ala Cys
Asp Thr Cys Ala
Glu Ala Cys Ser
Glu Ala Ser Cys
Glu Cys Ala Ser
Glu Cys Gly Thr
Glu Cys Ser Ala
Glu Cys Thr Gly
Glu Gly Cys Thr
Glu Gly Thr Cys
Glu Ser Ala Cys
Glu Ser Cys Ala
Glu Thr Cys Gly
Glu Thr Gly Cys
Gly Cys Glu Thr
Gly Cys Thr Glu
Gly Asp Met Ser
Gly Asp Ser Met
Gly Glu Cys Thr
Gly Glu Thr Cys
Gly Met Asp Ser
Gly Met Ser Asp
Gly Ser Asp Met
Gly Ser Met Asp
Gly Thr Cys Glu
Gly Thr Glu Cys
Met Asp Gly Ser
Met Asp Ser Gly
Met Gly Asp Ser
Met Gly Ser Asp
Met Ser Asp Gly
Met Ser Gly Asp
Ser Ala Cys Glu
Ser Ala Glu Cys
Ser Cys Ala Glu
Ser Cys Glu Ala
Ser Asp Gly Met
Ser Asp Met Gly
Ser Glu Ala Cys
Ser Glu Cys Ala
Ser Gly Asp Met
Ser Gly Met Asp
Ser Met Asp Gly
Ser Met Gly Asp
Thr Ala Cys Asp
Thr Ala Asp Cys
Thr Cys Ala Asp
Thr Cys Asp Ala
Thr Cys Glu Gly
Thr Cys Gly Glu
Thr Asp Ala Cys
Thr Asp Cys Ala
Thr Glu Cys Gly
Thr Glu Gly Cys
Thr Gly Cys Glu
Thr Gly Glu Cys
Torachrysone 8-glucoside
Torachrysone-8-O-b-D-glucoside could be isolated from root of Polygonum multiflorum. Torachrysone-8-O-b-D-glucoside increases the proliferation of DPCs (dermal papilla cells)[1]. Torachrysone-8-O-b-D-glucoside could be isolated from root of Polygonum multiflorum. Torachrysone-8-O-b-D-glucoside increases the proliferation of DPCs (dermal papilla cells)[1].
Wybutoxine
Marmesin galactoside
2,2-(5-Bromo-1,3-phenylene)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
Levamlodipine
C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C93038 - Cation Channel Blocker
Boc-S-benzyl-L-cysteine N-hydroxysuccinimide ester
3-[(dimethylvinylsilyl)oxy]-1,1,5,5-tetramethyl-3-phenyl-1,5-divinyltrisiloxane
[(1S,2S,6R)-5,6-diacetyloxy-1-hydroxy-2-(2-hydroxyethoxy)-1-cyclohex-3-enyl]methyl benzoate
bis[μ-[n,n-bis(1-methylethyl)-ethanimidamidato-κn:κn]]di-copper
N-(4-chloro-2-methylphenyl)-3-[4-(2-methylpropylsulfamoyl)phenyl]propanamide
2-[8-(acetyloxymethyl)-9-oxo-11H-indolizino[1,2-b]quinolin-7-yl]-2-hydroxybutanoic acid
Ginkgolid A
Ginkgolide A (BN-52020) is an extract from in Ginkgo biloba and a g-aminobutyric acid (GABA) antagonist. Ginkgolide A (BN-52020) is an extract from in Ginkgo biloba and a g-aminobutyric acid (GABA) antagonist. Ginkgolide A (BN-52020) is an extract from in Ginkgo biloba and a g-aminobutyric acid (GABA) antagonist.
3-[5-[Bis(3-methyl-5-oxo-1,2-dihydropyrazol-4-yl)methyl]-2-furanyl]benzoic acid methyl ester
2-(3,4-dimethoxyphenyl)-N-[(E)-[1-(4-nitrophenyl)pyrrol-2-yl]methylideneamino]acetamide
(1S,5R)-6-(benzenesulfonyl)-7-[4-(4-fluorophenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane
[(2R,3R)-6-[(2,5-difluorophenyl)methyl]-1-methylsulfonyl-3-phenyl-1,6-diazaspiro[3.3]heptan-2-yl]methanol
3-Ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-3,4-dihydropyridine-3,5-dicarboxylate
(1R,3R,6S,8S,10R,13S,16S,17R)-8-tert-butyl-6,17-dihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.01,11.03,7.07,11.013,17]nonadecane-5,15,18-trione
(1R,3R,6S,8S,10R,11R,13S,16S,17R)-8-tert-butyl-6,17-dihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.01,11.03,7.07,11.013,17]nonadecane-5,15,18-trione
8,9-Dihydro-8-[1-methyl-1-(beta-D-glucopyranosyloxy)ethyl]-2H-furo[2,3-h]-1-benzopyran-2-one
(1S,3R,6R,7S,8S,10R,13S,16S,17R)-8-tert-butyl-6,17-dihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0(1),(1)(1).0(3),.0,(1)(1).0(1)(3),(1)]nonadecane-5,15,18-trione
2-(15-Ethyl-3,5,6,7-tetrahydroxy-16-methyl-8-oxo-14,17-dioxatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4(9),10-trien-13-yl)acetic acid
5,9,14,18-Tetraoxo-5,6,7,8,9,14,15,16,17,18-decahydro-7,16-methanodinaphtho(2,3-A:23-F)cyclodecene
6,7,8,15,16,17-Hexahydro-7,16-methanocyclodeca[1,2-b:6,7-b]dinaphthalene-1,4,9,14-tetrone
(1R,3R,6R,8S,10R,13S,16S,17R)-8-tert-butyl-6,17-dihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0(1),(1)(1).0(3),.0,(1)(1).0(1)(3),(1)]nonadecane-5,15,18-trione
1-(1-hydroxy-8-methoxy-3-methyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-2-yl)ethanone
6-[(2z)-4-hydroxy-3-methylbut-2-en-1-yl]-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one
2-{2-[2-(3,4-dihydroxyphenyl)ethyl]-4-hydroxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
8-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl)-8h,9h-furo[2,3-h]chromen-2-one
(1s,4as,5r,7r,7as)-5,7-dihydroxy-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylic acid
5-(1,2-dihydroxyethyl)-4a-hydroxy-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,5h,6h-pyrano[3,4-c]pyran-1-one
8,8-dimethyl-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-9h,10h-pyrano[2,3-h]chromen-2-one
6-o-(4'-hydroxy-2'-methylene-butyryl)-1-o-cis-cinnamoyl-β-d-glucopyranose
{"Ingredient_id": "HBIN012581","Ingredient_name": "6-o-(4'-hydroxy-2'-methylene-butyryl)-1-o-cis-cinnamoyl-\u03b2-d-glucopyranose","Alias": "NA","Ingredient_formula": "C20H24O9","Ingredient_Smile": "C=C(CCO)C(=O)OCC1C(C(C(C(O1)OC(=O)C=CC2=CC=CC=C2)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10489","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-o-(4'-hydroxy-2'-methylene-butyryl)-1-o-trans-cinnamoyl-β-d-glucopyranose
{"Ingredient_id": "HBIN012582","Ingredient_name": "6-o-(4'-hydroxy-2'-methylene-butyryl)-1-o-trans-cinnamoyl-\u03b2-d-glucopyranose","Alias": "NA","Ingredient_formula": "C20H24O9","Ingredient_Smile": "C=C(CCO)C(=O)OCC1C(C(C(C(O1)OC(=O)C=CC2=CC=CC=C2)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10490","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-o-(trans-cinnamoyl)-1-o-(4''-hydroxy-3''-methylfuran-2''-one)-β-d-glucopyranose
{"Ingredient_id": "HBIN012718","Ingredient_name": "6-o-(trans-cinnamoyl)-1-o-(4''-hydroxy-3''-methylfuran-2''-one)-\u03b2-d-glucopyranose","Alias": "NA","Ingredient_formula": "C20H24O9","Ingredient_Smile": "CC1C(COC1=O)OC2C(C(C(C(O2)COC(=O)C=CC3=CC=CC=C3)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3707","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7-o-methylaloeresin
{"Ingredient_id": "HBIN013398","Ingredient_name": "7-o-methylaloeresin","Alias": "7-methoxy-5-methyl-2-(2-oxopropyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one; 7-O-Methylaloesin; AC1NSY7G","Ingredient_formula": "C20H24O9","Ingredient_Smile": "CC1=CC(=C(C2=C1C(=O)C=C(O2)CC(=O)C)C3C(C(C(C(O3)CO)O)O)O)OC","Ingredient_weight": "408.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT16532","TCMID_id": "14122","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5319505","DrugBank_id": "NA"}
abruquinone g
{"Ingredient_id": "HBIN014258","Ingredient_name": "abruquinone g","Alias": "NA","Ingredient_formula": "C20H24O9","Ingredient_Smile": "COC1=C(C(=C2C(=C1)C(C(CO2)C3=CC(=C(C(=C3O)OC)OC)O)O)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "26","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
